Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
British Journal of Cancer|July 14, 2012
Phase I dose-escalation study of aflibercept in combination with docetaxel and cisplatin in patients with advanced solid tumoursG Freyer, N Isambert, B You, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 12, 2012
Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: clinical activity and molecular response (GORTEC 2008-02)S Schmitz, M-C Kaminsky-Forrett, S Henry, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 26, 2011
Phase II study of carboplatin and etoposide in patients with anaplastic progressive metastatic castration-resistant prostate cancer (mCRPC) with or without neuroendocrine differentiation: results of the French Genito-Urinary Tumor Group (GETUG) P01 trialA Fléchon, D Pouessel, C Ferlay, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 25, 2015
First-line treatment with sunitinib for type 1 and type 2 locally advanced or metastatic papillary renal cell carcinoma: a phase II study (SUPAP) by the French Genitourinary Group (GETUG)†A Ravaud, S Oudard, M De Fromont, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 26, 2015
Cetuximab, docetaxel, and cisplatin as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, phase II GORTEC studyJ Guigay, J Fayette, A F Dillies, et al.
ESMO Open|March 4, 2026
Real-world external control arm for the single-arm LIBRETTO-001 trial of selpercatinib in RET-mutation-positive medullary thyroid cancer: RECALIB-RETJ Hadoux, J Hernando, K H Wong, et al.
Trials|July 3, 2024
Comparison of "IN-REC-SUR-E" and LISA in preterm neonates with respiratory distress syndrome: a randomized controlled trial (IN-REC-LISA trial)Giovanni Vento, Angela Paladini, C Aurilia, et al.
Pageof 2